BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27474397)

  • 21. Genome Editing in Mouse Zygotes and Embryonic Stem Cells by Introducing SgRNA/Cas9 Expressing Plasmids.
    Noda T; Oji A; Ikawa M
    Methods Mol Biol; 2017; 1630():67-80. PubMed ID: 28643250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient mouse genome engineering by CRISPR-EZ technology.
    Modzelewski AJ; Chen S; Willis BJ; Lloyd KCK; Wood JA; He L
    Nat Protoc; 2018 Jun; 13(6):1253-1274. PubMed ID: 29748649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome Editing in Mouse and Rat by Electroporation.
    Kaneko T
    Methods Mol Biol; 2017; 1630():81-89. PubMed ID: 28643251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple and large-scale chromosomal engineering of mouse zygotes via in vitro and in vivo electroporation.
    Iwata S; Nakadai H; Fukushi D; Jose M; Nagahara M; Iwamoto T
    Sci Rep; 2019 Oct; 9(1):14713. PubMed ID: 31604975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysing the outcome of CRISPR-aided genome editing in embryos: Screening, genotyping and quality control.
    Mianné J; Codner GF; Caulder A; Fell R; Hutchison M; King R; Stewart ME; Wells S; Teboul L
    Methods; 2017 May; 121-122():68-76. PubMed ID: 28363792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas9-Mediated Insertion of loxP Sites in the Mouse Dock7 Gene Provides an Effective Alternative to Use of Targeted Embryonic Stem Cells.
    Bishop KA; Harrington A; Kouranova E; Weinstein EJ; Rosen CJ; Cui X; Liaw L
    G3 (Bethesda); 2016 Jul; 6(7):2051-61. PubMed ID: 27175020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery of CRISPR-Cas9 into Mouse Zygotes by Electroporation.
    Qin W; Wang H
    Methods Mol Biol; 2019; 1874():179-190. PubMed ID: 30353514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient Genome Editing of Mice by CRISPR Electroporation of Zygotes.
    Diallo CK; Modzelewski AJ
    J Vis Exp; 2022 Dec; (190):. PubMed ID: 36591999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering Point Mutant and Epitope-Tagged Alleles in Mice Using Cas9 RNA-Guided Nuclease.
    Gertsenstein M; Nutter LMJ
    Curr Protoc Mouse Biol; 2018 Mar; 8(1):28-53. PubMed ID: 30040228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of Efficient Knock-in Mouse and Human Pluripotent Stem Cells Using CRISPR-Cas9.
    Anzai T; Hara H; Chanthra N; Sadahiro T; Ieda M; Hanazono Y; Uosaki H
    Methods Mol Biol; 2021; 2320():247-259. PubMed ID: 34302663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TEAD4 regulates trophectoderm differentiation upstream of CDX2 in a GATA3-independent manner in the human preimplantation embryo.
    Stamatiadis P; Cosemans G; Boel A; Menten B; De Sutter P; Stoop D; Chuva de Sousa Lopes SM; Lluis F; Coucke P; Heindryckx B
    Hum Reprod; 2022 Jul; 37(8):1760-1773. PubMed ID: 35700449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of introducing the CRISPR/Cas9 system by microinjection and electroporation into porcine embryos at different stages.
    Le QA; Tanihara F; Wittayarat M; Namula Z; Sato Y; Lin Q; Takebayashi K; Hirata M; Otoi T
    BMC Res Notes; 2021 Jan; 14(1):7. PubMed ID: 33407863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of Mouse Model (KI and CKO) via Easi-CRISPR.
    Shola DTN; Yang C; Han C; Norinsky R; Peraza RD
    Methods Mol Biol; 2021; 2224():1-27. PubMed ID: 33606203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of CRISPR/Cas9 for the Modification of the Mouse Genome.
    Klimke A; Güttler S; Kuballa P; Janzen S; Ortmann S; Flora A
    Methods Mol Biol; 2019; 1953():213-230. PubMed ID: 30912024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electroporation-Mediated CRISPR/Cas9 Genome Editing in Rat Zygotes.
    Davis DJ; Men H; Bryda EC
    Methods Mol Biol; 2023; 2631():267-276. PubMed ID: 36995672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct Generation of Conditional Alleles Using CRISPR/Cas9 in Mouse Zygotes.
    Pritchard CEJ; Kroese LJ; Huijbers IJ
    Methods Mol Biol; 2017; 1642():21-35. PubMed ID: 28815491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.
    Bai B; Myklebust JH; Wälchli S
    Methods Mol Biol; 2020; 2115():445-454. PubMed ID: 32006416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroporation of mice zygotes with dual guide RNA/Cas9 complexes for simple and efficient cloning-free genome editing.
    Teixeira M; Py BF; Bosc C; Laubreton D; Moutin MJ; Marvel J; Flamant F; Markossian S
    Sci Rep; 2018 Jan; 8(1):474. PubMed ID: 29323173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.